A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Clinical trial NCT01687478 · TERMINATED

Trial details

NCT number: NCT01687478
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Treatment Resistant Depression

Start date: 2012-09-01
Primary completion: 2015-11-01
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.